Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 11.21 M14.52 M— — Research & development 4.16 M4.45 M— — Operating income -6.5 M-9.04 M— — Non-Operating Income, Total 600 K1.46 M— — Interest expense, net of interest capitalized 363 K380 K— — Non-Operating Income, excl. Interest Expenses 501 K574 K— — Unusual income/expense -264 K509 K— — Pretax income 7.1 M10.5 M— — Equity in earnings ——— — Taxes 0012.15 M — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -6.77 M-8.53 M-8.61 M — Discontinued operations ——— — Net income -6.77 M-8.53 M-8.61 M — Dilution adjustment 13.53 M17.05 M— — Preferred dividends 00— — Diluted net income available to common stockholders 6.77 M8.53 M8.61 M — Basic earnings per share (Basic EPS) -1.47-0.4— — Diluted earnings per share (Diluted EPS) -1.47-0.4-0.61 — Average basic shares outstanding 4.45 M10.05 M14.22 M — Diluted shares outstanding 4.45 M10.05 M14.22 M — EBITDA -6.4 M-8.94 M— — EBIT -6.5 M-9.04 M— — Cost of revenue 3.21 M3.15 M— — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 100 K100 K— —